Oscar Health (OSCR) Stock Skyrockets – Major News & Analyst Insights (Oct 2025)
Oscar Health shares surged 11% to $21.50 on Oct. 3, 2025, after a weeklong 8% gain. Q2 revenue rose 28–30% to $2.9 billion, but the company posted a $228 million net loss on high medical costs. Management reaffirmed 2025 guidance and raised its revenue outlook in July. Analysts remain bearish, with a consensus “Strong Sell” rating and a $12 average price target.